Crossmark

Analysis of compliance and language use in broad informed consent forms in international multicenter clinical trials after the implementation of the 2018 common rule

Crossref DOI link: https://doi.org/10.1186/s12910-026-01483-7

Published Online: 2026-05-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Anek, Pannita

Dukaew, Nahathai

Morakote, Nimit

Kongta, Nattharinee

Na Takuathung, Mingkwan

Koonrungsesomboon, Nut
License Information

Text and Data Mining valid from 2026-05-20

Accepted Manuscript valid from 2026-05-20
More Information

Article History

Received: 1 December 2025

Accepted: 8 May 2026

First Online: 20 May 2026

Declarations

:

: Not applicable. This study received a certificate of exemption for review issued by the Research Ethics Committee of the Faculty of Medicine, Chiang Mai University. As the study did not involve human participants, consent to participate was not required.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below